We have previously generated SH42 as inhibitor of Δ24-dehydrocholesterol reductase (DHCR24), the enzyme catalyzing conversion of desmosterol into cholesterol,15 and showed that SH42 treatment increases desmosterol levels to enhance inflammation resolution in a peritonitis mouse model.16 Here, DHCR24 is linked to peritonitis.